JPALIHI@EC2604A

HSBC Raises Target Prices for JD Health and Alibaba Health

Alibaba Health Secures Systemic Licensing of People's Health Press Medical Publications

AliHealth's Medical AI Product Hydrogen Ion Reaches Content Collaboration with Chinese Medical Association

Alibaba Health's Hydrogen Ion Updates Precision Positioning Feature

Alibaba Health Pharmaceutical Chain Co., Ltd. Investigated for False Advertising

Alibaba Health Launches AI Product 'Hydroion'

Dain Biosea's Manlejing® Melatonin Granules Launched on Ali Health

Alibaba Health Partners with MeiLson for Pediatric Innovation Drug Cooperation

JPMorgan Increases Stake in Alibaba Health to 8.12%

Alibaba Health and Beijing Meiersen Announce Strategic Collaboration in Pediatric Specialty Innovative Drugs

Alibaba Health Special Shareholders' Meeting Approves Revision of Annual Cap for Marketing and Promotion Services

Huahuaic Jiangzhong Six Flavor Rehmannia Paste Launches on Ali Health

Alibaba Health and Guangzhou Pharmaceutical Sign Comprehensive Strategic Cooperation Agreement

Influenza Epidemic Leads to Surge in Demand for Anti-Influenza Drugs

Morgan Stanley Raises Target Price for AliHuang to HKD 4.6

Alibaba Health Reports Q3 2025 Financial Results

Alibaba Health Reports Strong First Half of Fiscal 2026, Revenue Reaches RMB 166.97 Billion

Guotai Junan Maintains Buy Rating on Ali Health Information Technology with Target Price of HKD 5.69

JPMorgan 增持阿里健康

Goldman Sachs Maintains Neutral Rating on Alibaba Health and Raises Target Price

TIMES UNI GP

CENTURY GINWA

STARGLORY HLDGS

RIDGE OUTDOOR

SYNAGISTICS

PROSP INV HOLD

HING LEE (HK)

ELEGANCEOPTICAL

CH ENV TECH&BIO

SHANGHAI QINGPU

00241

HSBC analyst maintained a Hold rating on Alibaba Health Information Technology (ALBHF) on February 9, setting a price target of HK$6.50. The stock closed at HK$6.27. The analyst consensus is a Moderate Buy with an average price target of HK$7.03, indicating a 12.18% upside. TipRanks also reiterated a Hold rating with the same price target of HK$6.50.

Tip Ranks

ALI HEALTH

Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC

TCTZF

00700

BABA

KBAB

BABX

TCEHY

CLOU

09988

According to Omdia, Mainland China's cloud infrastructure market grew 24% year-on-year to $13.4 billion in Q3 2025, marking the second consecutive quarter of over 20% growth. The demand for AI is driving this growth, with major players like Alibaba Cloud (36% market share), Huawei Cloud (16%), and Tencent Cloud (9%) enhancing their AI capabilities. Alibaba Cloud reported triple-digit growth in AI revenues, while Huawei Cloud and Tencent Cloud focused on industry-specific AI applications. The market is increasingly shifting towards platform-level reliability and operational stability as AI deployments scale.

- Mainland China’s cloud infrastructure services market reached $13.4 billion in Q3 2025, growing 24% year on year.  
- Major cloud providers like Alibaba Cloud, Huawei Cloud, and Tencent Cloud are enhancing their AI capabilities to meet increasing demand, with respective market shares of 36%, 16%, and 9%.  
- Partner-driven cloud revenue constituted 25% of the total market, highlighting the role of ecosystem collaboration in translating AI adoption into business value.

StockTitan

Tencent Holdings Limited

TENCENT

Alibaba

KraneShares 2x Long BABA Daily ETF

BABA 2x Long Daily ETF - GraniteShares

Tencent

Global X Cloud Computing ETF

BABA-W

Omdia: Mainland China’s cloud infrastructure market accelerates to 24% growth in Q3 2025 | TTGT Stock News

KWEB

159998

A forum titled 'Build and Scale in 2026' is being held in Hong Kong, organized by ChainCatcher, RootData, and Alibaba Cloud. Sponsored by Fortune Securities, the event focuses on industry trends and opportunities, featuring discussions on RWA, stablecoins, AI, payments, and DeFi. It aims to gather global project leaders, investment institutions, and developers to explore growth paths in the new cycle.

CoinLive

ARK Fintech Innovation ETF

E Fund CSI HK Connect Internet ETF

Hwabao CSI HK Equities Internet ETF

Global X Fintech

Amplify Transform Data Sharing ETF

Yinhua MSCI China A ETF

Krne Csi China Internet

Siren ETF Trust Siren Nasdaq NexGen Economy ETF

Tianhong CSI Computer Theme ETF

Hong Kong Forum to Explore Industry Trends and Opportunities in 2026

589720

06618

HSBC's research report pointed out that JD HEALTH and ALI HEALTH saw significant growth in drug sales last year. The target price for JD HEALTH has been raised to 77.5 yuan, maintaining a "Buy" rating. The target price for ALI HEALTH has been raised to 6.5 yuan, maintaining a "Hold" rating. It is expected that online drug sales growth will gradually return to normalization, but the structural trend of prescription outflow will support continued growth in online channels

AASTOCKS

Guotai SSE STAR Brand Name Drug ETF

JD HEALTH

"Large Banks" Huizheng: Online drug purchase market share continues to expand, JD HEALTH target price raised to 77.5 yuan

The Hang Seng Index opened 175 points higher this morning, reporting at 27,202 points. Among blue-chip stocks, ZIJIN MINING rose nearly 3%, and Pop Mart rose 2.4%. Tech stocks generally moved upward, with Tencent rising 0.5%, Xiaomi rising 0.8%, Baidu rising nearly 1%, and NetEase rising 2.4%. Alibaba's stock price rose 1.1%, and JD.com rose 1.2%. The new stock RIDGE OUTDOOR officially listed today, with a public offering recorded at 3,653 times oversubscribed. The US stock market continued to rebound, with the Dow Jones rising 20 points, the S&P 500 rising 32 points, and the Nasdaq rising 207 points

- The U.S. stock market continued its rebound, with the Dow Jones rising 20 points, the S&P 500 up 32 points, and the Nasdaq increasing by 207 points.  
- Alphabet plans to issue $20 billion in bonds, exceeding initial forecasts, with strong demand reported, while the Hang Seng Index saw gains led by tech stocks.  
- Interestingly, new offerings like Le Xin Outdoors reported extreme oversubscription, indicating significant investor interest in the Hong Kong market.

Stheadline

BIDU-SW

JD.com

ZIJIN MINING

JD-SW

CSOP HSI ETF

China Southern CSI SWS Non-Ferrous Metal ETF

Yinhua CSI Non-ferrous Metal ETF

AXA SPDB CSI Hugangshen Game and Culture Media ETF

CSOP HS TECH

KraneShares 2x Long JD Daily ETF

NTES-S

The Hang Seng Index opened up 175 points, tech stocks rose, Zijin Mining increased nearly 3%, and new stock Ridge Outdoor surged 96% | Hong Kong stock market opens

BABO

Alibaba's AI chatbot Qwen has halted coupon issuance due to overwhelming customer demand, impacting a campaign aimed at enhancing its shopping capabilities. The chatbot, which began offering coupons for in-app purchases, faced technical issues after 10 million orders were placed in just nine hours. Qwen requested users' patience as it works to manage the high volume of orders, assuring that coupons will remain valid until February 28. Alibaba has not commented on the technical challenges encountered during the rollout of its Agentic AI strategy.

- Alibaba's AI chatbot, Qwen, has paused coupon issuance due to overwhelming demand which has hindered its promotional campaign during the Spring Festival.  
- The initiative aims to integrate in-app purchases and is part of a 3-billion-yuan plan to enhance user engagement.  
- Despite achieving 10 million orders in the first nine hours, technical issues emerged, prompting Qwen to request users to temporarily refrain from placing orders.

Reuters

YieldMax BABA Option Income Strategy ETF

Alibaba's overloaded AI chatbot stops issuing coupons, asks shoppers for patience

Phoenix Finance will participate in the 'Build and Scale in 2026' forum on February 10 in Hong Kong, co-hosted by ChainCatcher, RootData, and Alibaba Cloud. The event is part of the Consensus HongKong conference and will focus on industry trends, growth paths, and market opportunities in sectors like RWA, stablecoins, AI, payments, and DeFi. Phoenix Finance, a yield-focused stablecoin protocol, aims to convert real-world assets into on-chain capital using an AI-driven yield engine. Its mainnet is live, allowing users to mint PUSD and earn yields through staking.

Circle

Coinbase

Grayscale Bitcoin Trust BTC - ETF

DAMAI ENT

Bitwise Bitcoin ETF

Invesco Galaxy Bitcoin ETF

ProShares Bitcoin Strategy ETF

WisdomTree Bitcoin Fund

VanEck Bitcoin ETF

Franklin Bitcoin ETF

Fidelity Wise Origin Bitcoin Fund - ETF

ARK 21Shares Bitcoin ETF

Phoenix Finance to Attend Hong Kong Forum on Future Industry Trends

Alibaba-W's Qianwen App launches a Spring Festival invitation plan, with the first round of free meal activities offering milk tea. Users can receive a 25 yuan free meal card to use at over 300,000 milk tea shops nationwide. Some users reported that the page displayed "The event is too popular, please try again later." This event is the largest investment Alibaba has made in its Spring Festival activities in history

Qianwen's Spring Festival banquet plan's first round of free meal activity offers milk tea, with users reporting the appearance of "Please try again later."

EBIZ

The NASDAQ Golden Dragon China Index's initial gain expanded to 1.21%. Popular Chinese concept stocks include Nio rising 7.4%, MINISO increasing 5.4%, YUM China up 3.4%, Li Auto up 2.8%, ZTO EXPRESS, Zai Lab, Bilibili, Baidu, and KINGSOFT CLOUD rising over 2%, Alibaba up 0.7%, XPeng down 1.2%, and New Oriental down 2.8%. Among ETFs, KWEB rose 1.14%, CQQQ increased 0.7%, ASHR fell 0.1%, and ASHS decreased 1.3%

Wallstreetcn

ZTO EXPRESS-W

NEW ORIENTAL-S

Bilibili

YUM CHINA

KINGSOFT CLOUD

New Oriental EDU & Tech

YUM China

NIO-SW

LI AUTO-W

NIO Inc. USD OV

NASDAQ Golden Dragon China Index

Amplify Online Retail ETF

Invesco Golden Dragon China

Global X China Consumer

Roundhill China Dragons ETF

iShares MSCI China

Invesco China Tech

Global X E-commerce ETF

The China concept index rose by 1.2%, Nio increased by over 7%, and Li Auto rose by about 3%

510660

512010

159849

159837

516500

159929

516610

Citi analyst maintained a Buy rating on Alibaba Health Information Technology today and set a price target of HK$9.00.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alibaba Health Information Technology with a HK$7.11 average price target.

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund CSI 300 Health Care ETF

China Merchants CSI Biotechnology Theme ETF

E Fund CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

China Universal 800 Health Care ETF

Dacheng CSI All Share Health Care Equipment and Services ETF

Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)

Aletheia Capital has maintained a Buy rating for Alibaba (BABA), with shares closing at $159.14. This follows a similar Buy rating from Arete Research's Shawn Yang on January 20. However, TipRanks reiterated a Hold rating on Alibaba on February 3.

- Aletheia Capital has reaffirmed a Buy rating on Alibaba, with shares closing at $159.14.  
- Arete Research also issued a Buy rating for Alibaba on January 20.  
- Conversely, TipRanks maintained a Hold rating on Alibaba as of February 3.

Aletheia Capital Sticks to Their Buy Rating for Alibaba (BABA)

00388

HKXCY

AAGIY

00005

01398

HSBH

601398

PNGAY

Hong Kong's American Depositary Receipts (ADRs) mostly continued to decline. According to RTHK, several blue-chip ADRs fell between 1% and over 2%. Meituan and Alibaba experienced significant drops, both declining by more than 2%, with their Hong Kong dollar equivalents at 90.3 and 155.4, respectively. Tencent, Xiaomi, Hong Kong Exchanges and Clearing, AIA, Ping An Insurance, Industrial and Commercial Bank of China, and Bank of China ADRs all decreased by over 1%. In contrast, HSBC's ADR rose by 0.5%, equivalent to 139.7 in Hong Kong dollars.

HKEX

Hong Kong Exchanges and Clearing (HKEX)

AIA Group

HSBC HOLDINGS

ICBC

HSBC Holdings plc ADRhedged

Ping An Insurance

Meituan

Xiaomi Corporation

MEITUAN

Hong Kong ADRs Experience Decline with Major Blue-Chip Losses

$XTALPI(02228.HK) Goldman Sachs launched the &#34;China AI Healthcare Index&#34; today, with Pharmaron as the top-weighted stock $ALI HEALTH(00241.HK)$JD HEALTH(06618.HK)$PA GOODDOCTOR(01833.HK)$YIDU TECH(02158.HK)$MircroPort Medbot-B(02252.HK)

JPALIHI@EC2604A(22070.HK)

Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC

Omdia: Mainland China’s cloud infrastructure market accelerates to 24% growth in Q3 2025 | TTGT Stock News

Hong Kong Forum to Explore Industry Trends and Opportunities in 2026

"Large Banks" Huizheng: Online drug purchase market share continues to expand, JD HEALTH target price raised to 77.5 yuan

The Hang Seng Index opened up 175 points, tech stocks rose, Zijin Mining increased nearly 3%, and new stock Ridge Outdoor surged 96% | Hong Kong stock market opens